| Accession Number | 0002010019-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Feb 2, 2026 | Sale | 80 | $228.50 | $18,280.00 | 142,406 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Feb 2, 2026 | Sale | 878 | $229.96 | $201,902.86 | 141,528 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Feb 2, 2026 | Sale | 576 | $230.84 | $132,963.78 | 140,952 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Feb 2, 2026 | Sale | 850 | $232.33 | $197,476.51 | 140,102 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Feb 2, 2026 | Sale | 600 | $233.24 | $139,942.02 | 139,502 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Feb 2, 2026 | Sale | 16 | $234.00 | $3,744.00 | 139,486 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Feb 3, 2026 | Sale | 1,639 | $230.77 | $378,228.75 | 137,847 | Direct | โ | View Details |